Merck & Co. Inc. buy StockNews.com
Start price
03.02.24
/
50%
€117.00
Target price
03.02.25
-
Performance (%)
-17.52%
End price
04.02.25
€96.50
Summary
This prediction ended on 04.02.25 with a price of €96.50. The prediction for Merck & Co. Inc. disappointed with a performance of -17.52%. StockNews_com has a follow-up prediction for Merck & Co. Inc. where he still thinks Merck & Co. Inc. is a Buy. Dividends of €2.89 are taken into consideration when calculating the performance. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merck & Co. Inc. | 11.206% | 11.206% | 76.011% |
| iShares Core DAX® | -1.283% | 4.209% | 7.084% |
| iShares Nasdaq 100 | -3.338% | -1.744% | 26.177% |
| iShares Nikkei 225® | -4.286% | -1.621% | 44.320% |
| iShares S&P 500 | -2.311% | -0.096% | 20.823% |
Comments by StockNews_com for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for MRK provided by MarketBeat
In the thread Trading Merck & Co. Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten